We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Updated: 12/31/1969
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Updated: 12/31/1969
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Updated: 12/31/1969
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Updated: 12/31/1969
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Texture Analysis for Postmenopausal Osteoporosis
Updated: 12/31/1969
Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis
Status: Enrolling
Updated: 12/31/1969
Texture Analysis for Postmenopausal Osteoporosis
Updated: 12/31/1969
Changes in Bone Density, Radiographic Texture Analysis and Bone Turnover During Two Years of Antiresorptive Therapy for Postmenopausal Osteoporosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Updated: 12/31/1969
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Status: Enrolling
Updated: 12/31/1969
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Updated: 12/31/1969
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
Updated: 12/31/1969
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals
Status: Enrolling
Updated: 12/31/1969
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
Updated: 12/31/1969
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Transplant Patient Registry of Liver, Kidney and/or Pancreas
Updated: 12/31/1969
Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas
Status: Enrolling
Updated: 12/31/1969
Transplant Patient Registry of Liver, Kidney and/or Pancreas
Updated: 12/31/1969
Transplant Registry: Patients Who May Require Transplantation and Those Who Have Undergone Transplantation of Liver, Kidney and/or Pancreas
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
Updated: 12/31/1969
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
Status: Enrolling
Updated: 12/31/1969
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
Updated: 12/31/1969
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
Updated: 12/31/1969
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients; a Comparative Study With a Non-transplant Population
Status: Enrolling
Updated: 12/31/1969
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
Updated: 12/31/1969
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients; a Comparative Study With a Non-transplant Population
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Updated: 12/31/1969
A Phase II Trial of Preoperative Irinotecan, Cisplatin and Radiation in Esophageal Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Wound Infection Alexis Wound Retractor
Updated: 12/31/1969
Rate of Surgical Wound Infection After Open Appendectomy Using the Alexis Wound Retractor
Status: Enrolling
Updated: 12/31/1969
Wound Infection Alexis Wound Retractor
Updated: 12/31/1969
Rate of Surgical Wound Infection After Open Appendectomy Using the Alexis Wound Retractor
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Colonic Tube to Improve Bowel Function in Spinal Cord Injury
Updated: 12/31/1969
Percutaneous Colostomy for Bowel Management in Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
A Colonic Tube to Improve Bowel Function in Spinal Cord Injury
Updated: 12/31/1969
Percutaneous Colostomy for Bowel Management in Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Selenium for Prevention of Adenomatous Colorectal Polyps
Updated: 12/31/1969
Phase III Study of the Effects of Selenium on Adenomatous Polyp Recurrence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Updated: 12/31/1969
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Status: Enrolling
Updated: 12/31/1969
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Updated: 12/31/1969
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Updated: 12/31/1969
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Status: Enrolling
Updated: 12/31/1969
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Updated: 12/31/1969
Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sirolimus for Autoimmune Disease of Blood Cells
Updated: 12/31/1969
Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
Status: Enrolling
Updated: 12/31/1969
Sirolimus for Autoimmune Disease of Blood Cells
Updated: 12/31/1969
Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis
Updated: 12/31/1969
Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis
Status: Enrolling
Updated: 12/31/1969
Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis
Updated: 12/31/1969
Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Establishing the Vitamin D Requirements During Lactation
Updated: 12/31/1969
Establishing the Vitamin D Requirements During Lactation
Status: Enrolling
Updated: 12/31/1969
Establishing the Vitamin D Requirements During Lactation
Updated: 12/31/1969
Establishing the Vitamin D Requirements During Lactation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Establishing the Vitamin D Requirements During Lactation
Updated: 12/31/1969
Establishing the Vitamin D Requirements During Lactation
Status: Enrolling
Updated: 12/31/1969
Establishing the Vitamin D Requirements During Lactation
Updated: 12/31/1969
Establishing the Vitamin D Requirements During Lactation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
Updated: 12/31/1969
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms
Status: Enrolling
Updated: 12/31/1969
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
Updated: 12/31/1969
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
Updated: 12/31/1969
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms
Status: Enrolling
Updated: 12/31/1969
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC
Updated: 12/31/1969
Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC to Problematic Gram-negative Organisms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cholic Acid for Hepatic Steatosis in Lipodystrophy
Updated: 12/31/1969
Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
Status: Enrolling
Updated: 12/31/1969
Cholic Acid for Hepatic Steatosis in Lipodystrophy
Updated: 12/31/1969
Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials